Table 1. Baseline patient and disease characteristics at initial diagnosis in each group.
Characteristic | Group 1 [n=42] | Group 2 [n=30] |
---|---|---|
Median age [range] [years] | 60 [41-79] | 61 [42-82] |
Sex | ||
Male | 27 (64.3%) | 18 (60.0%) |
Female | 15 (35.7%) | 12 (40.0%) |
Myeloma type | ||
IgG | 18 (42.9%) | 12 (40.0%) |
IgA | 9 (21.4%) | 7 (23.3%) |
IgD | 3 (7.1%) | 3 (10.0%) |
λ-light | 4 (9.5%) | 2 (6.7%) |
κ-light | 8 (19.0%) | 6 (20.0%) |
Level of Scr (mg/dL), median (range) | 1.2 (0.6-1.9) | 3.9 (2.2-13.7)* |
*Twelve patients in group 2 received hemodialysis at diagnosis